Equity Details
Price & Market Data
Price: $1.00
Daily Change: +$0.0096 / 0.96%
Daily Range: $0.985 - $1.02
Market Cap: $42,862,528
Daily Volume: 67,666
About MIRA Pharmaceuticals, Inc. (MIRA)
A complete market overview for MIRA Pharmaceuticals, Inc. (MIRA). The stock is at 1.00, with a daily change of +$0.0096 / 0.96%. Market cap: 42,862,528. Delve into its YTD and 3-month performance.
Company Details
Employees: 2
Sector: Health technology
Industry: Pharmaceuticals: other
Country: United States
Details
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.